168 related articles for article (PubMed ID: 28117030)
1. Three Combined Treatments, a Novel HDAC Inhibitor OBP-801/YM753, 5-Fluorouracil, and Paclitaxel, Induce G₂ Phase Arrest Through the p38 Pathway in Human Ovarian Cancer Cells.
Akiyama M; Sowa Y; Taniguchi T; Watanabe M; Yogosawa S; Kitawaki J; Sakai T
Oncol Res; 2017 Sep; 25(8):1245-1252. PubMed ID: 28117030
[TBL] [Abstract][Full Text] [Related]
2. The novel HDAC inhibitor OBP-801/YM753 enhances the effects of 5-fluorouracil with radiation on esophageal squamous carcinoma cells.
Furutani A; Sowa Y; Fujiwara H; Otsuji E; Sakai T
Oncol Res; 2014; 21(5):281-6. PubMed ID: 24854104
[TBL] [Abstract][Full Text] [Related]
3. Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways.
Yuan JP; Wang GH; Ling H; Su Q; Yang YH; Song Y; Tang RJ; Liu Y; Huang C
World J Gastroenterol; 2004 Sep; 10(18):2731-4. PubMed ID: 15309729
[TBL] [Abstract][Full Text] [Related]
4. Combination of a novel HDAC inhibitor OBP-801/YM753 and a PI3K inhibitor LY294002 synergistically induces apoptosis in human endometrial carcinoma cells due to increase of Bim with accumulation of ROS.
Yoshioka T; Yogosawa S; Yamada T; Kitawaki J; Sakai T
Gynecol Oncol; 2013 May; 129(2):425-32. PubMed ID: 23403163
[TBL] [Abstract][Full Text] [Related]
5. p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis.
Coltella N; Rasola A; Nano E; Bardella C; Fassetta M; Filigheddu N; Graziani A; Comoglio PM; Di Renzo MF
Int J Cancer; 2006 Jun; 118(12):2981-90. PubMed ID: 16395709
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
[TBL] [Abstract][Full Text] [Related]
7. Lidamycin induces marked G2 cell cycle arrest in human colon carcinoma HT-29 cells through activation of p38 MAPK pathway.
Liu X; Bian C; Ren K; Jin H; Li B; Shao RG
Oncol Rep; 2007 Mar; 17(3):597-603. PubMed ID: 17273739
[TBL] [Abstract][Full Text] [Related]
8. Cooperative function of Chk1 and p38 pathways in activating G2 arrest following exposure to temozolomide.
Hirose Y; Katayama M; Berger MS; Pieper RO
J Neurosurg; 2004 Jun; 100(6):1060-5. PubMed ID: 15200121
[TBL] [Abstract][Full Text] [Related]
9. ERK and p38 MAPK signaling pathways are involved in ochratoxin A-induced G2 phase arrest in human gastric epithelium cells.
Wang Y; Liu J; Cui J; Xing L; Wang J; Yan X; Zhang X
Toxicol Lett; 2012 Mar; 209(2):186-92. PubMed ID: 22230261
[TBL] [Abstract][Full Text] [Related]
10. The p53 pathway is synergized by p38 MAPK signaling to mediate 11,11'-dideoxyverticillin-induced G2/M arrest.
Chen Y; Miao ZH; Zhao WM; Ding J
FEBS Lett; 2005 Jul; 579(17):3683-90. PubMed ID: 15963507
[TBL] [Abstract][Full Text] [Related]
11. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
Bacus SS; Gudkov AV; Lowe M; Lyass L; Yung Y; Komarov AP; Keyomarsi K; Yarden Y; Seger R
Oncogene; 2001 Jan; 20(2):147-55. PubMed ID: 11313944
[TBL] [Abstract][Full Text] [Related]
12. Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells.
Sun WJ; Huang H; He B; Hu DH; Li PH; Yu YJ; Zhou XH; Lv Z; Zhou L; Hu TY; Yao ZC; Lu MD; Shen X; Zheng ZQ
Biochem Pharmacol; 2017 Mar; 127():90-100. PubMed ID: 28012958
[TBL] [Abstract][Full Text] [Related]
13. Suberoylanilide hydroxamic acid partly reverses resistance to paclitaxel in human ovarian cancer cell lines.
Angelucci A; Mari M; Millimaggi D; Giusti I; Carta G; Bologna M; Dolo V
Gynecol Oncol; 2010 Dec; 119(3):557-63. PubMed ID: 20825984
[TBL] [Abstract][Full Text] [Related]
14. [Diallyl disulfide-induced G2/M arrest of human gastric cancer MGC803 cells involves activation of p38 MAP kinase pathways].
Yuan JP; Ling H; Zhang MX; Liu Y; Song Y; Su Q
Ai Zheng; 2004 Feb; 23(2):169-72. PubMed ID: 14960237
[TBL] [Abstract][Full Text] [Related]
15. A monomer purified from Paris polyphylla (PP-22) triggers S and G2/M phase arrest and apoptosis in human tongue squamous cell carcinoma SCC-15 by activating the p38/cdc25/cdc2 and caspase 8/caspase 3 pathways.
Ke JY; Zhang W; Gong RS; Cen WJ; Huang HQ; Li YR; Kong WD; Jiang JW
Tumour Biol; 2016 Nov; 37(11):14863-14872. PubMed ID: 27644244
[TBL] [Abstract][Full Text] [Related]
16. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.
Hsu YL; Kuo PL; Lin LT; Lin CC
J Pharmacol Exp Ther; 2005 Apr; 313(1):333-44. PubMed ID: 15626723
[TBL] [Abstract][Full Text] [Related]
17. Acetyl-macrocalin B, an ent-kaurane diterpenoid, initiates apoptosis through the ROS-p38-caspase 9-dependent pathway and induces G2/M phase arrest via the Chk1/2-Cdc25C-Cdc2/cyclin B axis in non-small cell lung cancer.
Wang JN; Zhang ZR; Che Y; Yuan ZY; Lu ZL; Li Y; Li N; Wan J; Sun HD; Sun N; Puno PT; He J
Cancer Biol Ther; 2018 Jul; 19(7):609-621. PubMed ID: 29565730
[TBL] [Abstract][Full Text] [Related]
18. c-Jun N-terminal kinase mediates microtubule-depolymerizing agent-induced microtubule depolymerization and G2/M arrest in MCF-7 breast cancer cells.
Chen J; Sun WL; Wasylyk B; Wang YP; Zheng H
Anticancer Drugs; 2012 Jan; 23(1):98-107. PubMed ID: 21968419
[TBL] [Abstract][Full Text] [Related]
19. Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines.
Dietrich CS; Greenberg VL; DeSimone CP; Modesitt SC; van Nagell JR; Craven R; Zimmer SG
Gynecol Oncol; 2010 Jan; 116(1):126-30. PubMed ID: 19875160
[TBL] [Abstract][Full Text] [Related]
20. Acetyl-macrocalin B suppresses tumor growth in esophageal squamous cell carcinoma and exhibits synergistic anti-cancer effects with the Chk1/2 inhibitor AZD7762.
Wang JN; Che Y; Yuan ZY; Lu ZL; Li Y; Zhang ZR; Li N; Li RD; Wan J; Sun HD; Sun N; Puno PT; He J
Toxicol Appl Pharmacol; 2019 Feb; 365():71-83. PubMed ID: 30633885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
